Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will present new data at IDWeek 2024 focused on ...

The findings are significant for the liver research community and others interested in the gut-liver axis. (A) AOAH cleaves the two piggyback fatty acyl chains from the lipid A moiety, inactivating ...

Research explores how excessive sugar consumption can drive systemic inflammation, disrupt the gut and oral microbiomes, and contribute to periodontal inflammation, with implications for global health ...

This valuable study on strategies used by Pseudomonas to subvert hots immunity identifies a new immune evasion strategy. The study presents solid evidence on the cleavage of VgrG2B by Caspase 11 and ...

DeepCure, a therapeutics company using AI to discover novel drugs for inflammation and immune diseases, today announced it will present data showing its selective BRD4 (BD2) inhibitor DC-9476 is super ...

By Dr. Priyom Bose, Ph.D. New study uncovers how antibody combinations synergistically boost complement activation to combat ...

Many studies have shown that lipopolysaccharides (LPS) derived from the Prevotella genus are involved in mucosal barrier inflammatory responses, explain the researchers. Prevotella bivia, for example, ...

Once a suggestion is made, Google often accepts the changes without checking with organizations for accuracy, according to Mindy Burbach, executive director of communications at LPS. The schools ...